insights_auto
Why is CONCORDBIO down 3.77%?
Dive Deeperchevron_right
CONCORDBIO:NSE
Concord Biotech Ltd
₹1,288.50
arrow_downward
-3.77%(-50.50) 1D
Oct 19, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹1,350.00
High
₹1,350.00
Low
₹1,276.10
Mkt. cap
134.80B
Avg. vol.
132.57K
Volume
79.84K
Dividend
0.59%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
48.98
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
Open
₹1,350.00
High
₹1,350.00
Low
₹1,276.10
Mkt. cap
134.80B
Avg. vol.
132.57K
Volume
79.84K
Dividend
0.59%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
48.98
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
News stories
From web sources and news partners
FXStreet
·
1 hour ago
The S&P 500 is on a dangerous path
bloomingbit
·
34 minutes ago
U.S. Stocks Turn Higher; Nasdaq Up 1.36%
www.marketscreener.com
·
1 hour ago
FactSet Research : Are “Magnificent 7” Companies Still Top Contributors to S&P 500 Earnings Growth for Q3
TradingView
·
3 hours ago
The Dow Jones Index Opens 0.08% Lower
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd